Tag Archives: Zogenix

← Older posts Newer posts →

Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy

Pernix Therapeutics is slashing its headcount by more than 20 percent as the specialty pharmaceutical company tries to move toward profitability after a streak of acquisitions. Morristown, NJ-based Pernix (NASDAQ: PTX) will cut 60 workers, mostly from its neurology sales staff, the company said today. As of the end of 2015, Pernix reported a headcount […]

Posted in National blog main, New York, New York blog main, New York top stories, Raleigh-Durham blog main, San Diego blog main, Texas blog main | Tagged , , , , , , | Comments Off on Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy

West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More

A is for all the news up and down the West Coast this week, and much of that news was both about bio and tech. Apple launched an iPhone-based medical research platform, 23andMe has hired a former Genentech star to turn its genomic database into a drug discovery platform, and Google is expanding its genomic […]

Posted in National blog main, San Diego blog main, San Diego top stories, San Francisco, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More

In Move That Spells Relief, Zogenix Sells Painkiller to Pernix

Zohydro was supposed to be a new kind of painkiller, but it gave Zogenix CEO Roger Hawley a headache that lasted more than a year. Now perhaps he can rest a little easier. After introducing Zohydro in the United States almost exactly a year ago, San Diego-based Zogenix (NASDAQ: ZGNX) said today it has agreed […]

Posted in National blog main, National top stories, New York blog main, New York top stories, San Diego, San Diego blog main, San Diego top stories | Tagged , , , , , , , , , , , , , , , , , , , | 1 Comment

West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More

Amgen keeps adding to the layoffs, the governor of Washington has a lot to say to Xconomy about his state’s life sciences industry, and San Francisco’s Fibrogen hopes to crank up the IPO engine. Let’s get to the roundup. —Under hedge fund pressure to break itself up, Amgen (NASDAQ: AMGN) of Thousand Oaks, CA, instead […]

Posted in National blog main, National top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle, Seattle blog main, Seattle top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More

San Diego Life Sciences Roundup: Ambit, Zogenix, Aethlon, and More

Assessing the extent of long-term brain damage from concussions in football and other impact sports can be difficult (to say the least) if the only way to determine whether an individual is suffering from Chronic Traumatic Encephalopathy is by autopsy. So it’s interesting when a little-known life sciences company like San Diego’s Aethlon Medical starts […]

Posted in National blog main, San Diego, San Diego blog main, San Diego top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on San Diego Life Sciences Roundup: Ambit, Zogenix, Aethlon, and More

San Diego Life Sciences Roundup: Otonomy, Verdezyne, and IPOs

It was another busy week for San Diego’s life sciences sector. Here’s my roundup. —The federal Jumpstart Our Business Startups (JOBS) Act that was enacted two years ago has made it easier for life sciences companies to “test the waters” with potential investors in stealth mode before launching their IPOs. A record-setting 23 life sciences […]

Posted in National blog main, San Diego, San Diego blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on San Diego Life Sciences Roundup: Otonomy, Verdezyne, and IPOs

San Diego Life Sciences Roundup: Celladon, Halozyme, Zogenix, & More

A big drop in biotech stocks set the backdrop for much of the news out of San Diego’s life sciences community this week. The tide rises, and the tide falls. But the surf is forever—at least in San Diego. —A broad selloff in biotech stocks has prompted widespread concern that the biotech bubble is popping. […]

Posted in National blog main, National top stories, San Diego, San Diego blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on San Diego Life Sciences Roundup: Celladon, Halozyme, Zogenix, & More

San Diego Life Sciences Roundup: Zogenix, Arena, Sorrento, and More

San Diego’s Zogenix ran up against new political opposition to its opioid pain-killer, Zohydro. I have a rundown on the latest chapter in the ongoing Zohydro saga, along with the rest of the local life sciences news. —Massachusetts Governor Deval Patrick declared a statewide public health emergency last week to combat the growing abuse of […]

Posted in National blog main, San Diego, San Diego blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on San Diego Life Sciences Roundup: Zogenix, Arena, Sorrento, and More

San Diego Life Sciences Roundup: Zogenix, Ignyta, AnaptysBio, & More

[Updated 3/18/14 10:05 am. See below.] Here is a quick rundown of the strategic partnerships, funding deals, clinical trials, and other developments that kept San Diego’s life sciences sector hopping last week. —San Diego-based AnaptysBio and Waltham, MA-based Tesaro (NASDAQ: TSRO) agreed to collaborate in the development of certain antibody drug candidates that could be […]

Posted in National blog main, San Diego, San Diego blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on San Diego Life Sciences Roundup: Zogenix, Ignyta, AnaptysBio, & More

San Diego Life Sciences Roundup: Thesan, Zogenix, Illumina, and More

The battle continues over an extended-release formulation of a potent opioid painkiller developed by San Diego’s Zogenix. I have the details, along with the rest of the region’s life sciences news over the past week. —San Diego’s Thesan Pharmaceuticals said it has raised $49 million in a Series B round of equity funding to advance […]

Posted in National blog main, San Diego, San Diego blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on San Diego Life Sciences Roundup: Thesan, Zogenix, Illumina, and More← Older posts Newer posts →